Celera to Split from Applera

Applera’s intent regarding Celera advanced with the filing of an S-1 registration document with the SEC. Celera’s six-month sales for fiscal 2008 ended December 31, 2007 rose 141% to $56.5 million.

Norwalk, CT 2/29/08—Applera has announced its Celera subsidiary, one of the company’s two tracking stocks, along with Applied Biosystems, will pursue a possible spin-off from Applera to become a separately traded public firm (see IBO 8/15/07). Celera provides diagnostic products and services. Holders of the Celera tracking stock would receive Celera shares in a one-for-one exchange. Celera’s current president, Kathy Ordoñez, would become CEO and the company’s headquarters would be in Alameda, California.

< | >